vs

Side-by-side financial comparison of ARTESIAN RESOURCES CORP (ARTNA) and STANDARD BIOTOOLS INC. (LAB). Click either name above to swap in a different company.

ARTESIAN RESOURCES CORP is the larger business by last-quarter revenue ($28.0M vs $19.6M, roughly 1.4× STANDARD BIOTOOLS INC.). ARTESIAN RESOURCES CORP runs the higher net margin — 14.8% vs -177.4%, a 192.2% gap on every dollar of revenue. On growth, ARTESIAN RESOURCES CORP posted the faster year-over-year revenue change (4.3% vs -11.5%). ARTESIAN RESOURCES CORP produced more free cash flow last quarter ($-7.9M vs $-23.1M). Over the past eight quarters, ARTESIAN RESOURCES CORP's revenue compounded faster (6.8% CAGR vs -12.2%).

Artesian Resources Corp is a US-headquartered regulated water utility and wastewater service provider, primarily serving residential, commercial, industrial and municipal customers across Delaware. It focuses on delivering safe, reliable drinking water supply and sustainable wastewater treatment solutions to local communities.

Standard BioTools Inc., previously known as Fluidigm Corp., is an American life science tools company that offers analytical mass cytometry systems for flow cytometry and tissue imaging, along with associated assays and reagents, as well as an automated genomic analysis instrument and a variety of microfluidic arrays, or integrated fluidic circuits (IFCs), and consumables with fully kitted reagents. Custom assays and services are available with all systems and applications.

ARTNA vs LAB — Head-to-Head

Bigger by revenue
ARTNA
ARTNA
1.4× larger
ARTNA
$28.0M
$19.6M
LAB
Growing faster (revenue YoY)
ARTNA
ARTNA
+15.8% gap
ARTNA
4.3%
-11.5%
LAB
Higher net margin
ARTNA
ARTNA
192.2% more per $
ARTNA
14.8%
-177.4%
LAB
More free cash flow
ARTNA
ARTNA
$15.2M more FCF
ARTNA
$-7.9M
$-23.1M
LAB
Faster 2-yr revenue CAGR
ARTNA
ARTNA
Annualised
ARTNA
6.8%
-12.2%
LAB

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
ARTNA
ARTNA
LAB
LAB
Revenue
$28.0M
$19.6M
Net Profit
$4.1M
$-34.7M
Gross Margin
48.5%
Operating Margin
20.6%
-168.5%
Net Margin
14.8%
-177.4%
Revenue YoY
4.3%
-11.5%
Net Profit YoY
7.5%
-28.8%
EPS (diluted)
$0.39
$-0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARTNA
ARTNA
LAB
LAB
Q4 25
$28.0M
Q3 25
$30.5M
$19.6M
Q2 25
$28.5M
$21.8M
Q1 25
$25.9M
$40.8M
Q4 24
$26.9M
Q3 24
$29.1M
$22.1M
Q2 24
$27.4M
$22.5M
Q1 24
$24.5M
$45.5M
Net Profit
ARTNA
ARTNA
LAB
LAB
Q4 25
$4.1M
Q3 25
$7.0M
$-34.7M
Q2 25
$6.3M
$-33.5M
Q1 25
$5.4M
$-26.0M
Q4 24
$3.8M
Q3 24
$6.8M
$-26.9M
Q2 24
$5.3M
$-45.7M
Q1 24
$4.4M
$-32.2M
Gross Margin
ARTNA
ARTNA
LAB
LAB
Q4 25
Q3 25
48.5%
Q2 25
48.8%
Q1 25
48.4%
Q4 24
Q3 24
54.9%
Q2 24
46.1%
Q1 24
53.1%
Operating Margin
ARTNA
ARTNA
LAB
LAB
Q4 25
20.6%
Q3 25
28.3%
-168.5%
Q2 25
27.5%
-118.1%
Q1 25
21.4%
-80.8%
Q4 24
21.0%
Q3 24
29.5%
-120.9%
Q2 24
26.3%
-134.5%
Q1 24
19.2%
-132.2%
Net Margin
ARTNA
ARTNA
LAB
LAB
Q4 25
14.8%
Q3 25
22.8%
-177.4%
Q2 25
22.0%
-153.7%
Q1 25
21.0%
-63.8%
Q4 24
14.3%
Q3 24
23.4%
-122.0%
Q2 24
19.4%
-203.3%
Q1 24
18.0%
-70.6%
EPS (diluted)
ARTNA
ARTNA
LAB
LAB
Q4 25
$0.39
Q3 25
$0.68
$-0.09
Q2 25
$0.61
$-0.09
Q1 25
$0.53
$-0.07
Q4 24
$0.37
Q3 24
$0.66
$-0.07
Q2 24
$0.52
$-0.12
Q1 24
$0.43
$-0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARTNA
ARTNA
LAB
LAB
Cash + ST InvestmentsLiquidity on hand
$52.0K
$129.4M
Total DebtLower is stronger
$176.4M
Stockholders' EquityBook value
$249.9M
$399.7M
Total Assets
$851.2M
$539.6M
Debt / EquityLower = less leverage
0.71×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARTNA
ARTNA
LAB
LAB
Q4 25
$52.0K
Q3 25
$705.0K
$129.4M
Q2 25
$349.0K
$158.6M
Q1 25
$3.7M
$150.9M
Q4 24
$1.1M
Q3 24
$10.7M
$210.6M
Q2 24
$6.3M
$269.8M
Q1 24
$9.5M
$287.1M
Total Debt
ARTNA
ARTNA
LAB
LAB
Q4 25
$176.4M
Q3 25
Q2 25
Q1 25
Q4 24
$178.7M
Q3 24
$55.2M
Q2 24
$55.1M
Q1 24
$55.0M
Stockholders' Equity
ARTNA
ARTNA
LAB
LAB
Q4 25
$249.9M
Q3 25
$248.8M
$399.7M
Q2 25
$244.9M
$424.5M
Q1 25
$241.7M
$454.6M
Q4 24
$239.2M
Q3 24
$238.3M
$489.3M
Q2 24
$234.4M
$510.3M
Q1 24
$232.0M
$577.3M
Total Assets
ARTNA
ARTNA
LAB
LAB
Q4 25
$851.2M
Q3 25
$833.9M
$539.6M
Q2 25
$819.3M
$557.0M
Q1 25
$808.9M
$579.6M
Q4 24
$798.6M
Q3 24
$796.0M
$681.5M
Q2 24
$783.1M
$708.7M
Q1 24
$798.6M
$777.7M
Debt / Equity
ARTNA
ARTNA
LAB
LAB
Q4 25
0.71×
Q3 25
Q2 25
Q1 25
Q4 24
0.75×
Q3 24
0.11×
Q2 24
0.11×
Q1 24
0.10×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARTNA
ARTNA
LAB
LAB
Operating Cash FlowLast quarter
$10.5M
$-22.2M
Free Cash FlowOCF − Capex
$-7.9M
$-23.1M
FCF MarginFCF / Revenue
-28.1%
-118.1%
Capex IntensityCapex / Revenue
65.4%
4.5%
Cash ConversionOCF / Net Profit
2.53×
TTM Free Cash FlowTrailing 4 quarters
$-18.5M
$-111.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARTNA
ARTNA
LAB
LAB
Q4 25
$10.5M
Q3 25
$11.0M
$-22.2M
Q2 25
$7.9M
$-20.7M
Q1 25
$11.0M
$-30.3M
Q4 24
$6.7M
Q3 24
$10.7M
$-27.9M
Q2 24
$6.9M
$-39.0M
Q1 24
$12.6M
$-62.5M
Free Cash Flow
ARTNA
ARTNA
LAB
LAB
Q4 25
$-7.9M
Q3 25
$-3.3M
$-23.1M
Q2 25
$-7.9M
$-22.6M
Q1 25
$560.0K
$-35.3M
Q4 24
$-8.3M
Q3 24
$-1.9M
$-30.1M
Q2 24
$-2.6M
$-41.0M
Q1 24
$3.7M
$-63.3M
FCF Margin
ARTNA
ARTNA
LAB
LAB
Q4 25
-28.1%
Q3 25
-10.7%
-118.1%
Q2 25
-27.8%
-103.6%
Q1 25
2.2%
-86.6%
Q4 24
-30.9%
Q3 24
-6.5%
-136.4%
Q2 24
-9.4%
-182.2%
Q1 24
15.0%
-138.9%
Capex Intensity
ARTNA
ARTNA
LAB
LAB
Q4 25
65.4%
Q3 25
46.7%
4.5%
Q2 25
55.6%
8.7%
Q1 25
40.2%
12.4%
Q4 24
55.9%
Q3 24
43.1%
10.2%
Q2 24
34.5%
8.6%
Q1 24
36.4%
1.7%
Cash Conversion
ARTNA
ARTNA
LAB
LAB
Q4 25
2.53×
Q3 25
1.58×
Q2 25
1.26×
Q1 25
2.02×
Q4 24
1.74×
Q3 24
1.56×
Q2 24
1.29×
Q1 24
2.86×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ARTNA
ARTNA

Water Sales$22.3M80%
Other Utility Operating Revenue$3.8M14%
Non Utility Operating Revenue$1.9M7%

LAB
LAB

Consumables$8.7M45%
Services And Other Revenue$5.8M29%
Instruments$5.1M26%

Related Comparisons